Loading company…
Biopharmaceutical company developing 3pRNA-based immunotherapeutics for cancer and viral diseases.
Established in 2014 and based in Bonn, Germany, Rigontec GmbH is a biopharmaceutical company that develops 3pRNA-based immunotherapeutics for the treatment of cancer and viral diseases. Its headquarters are listed in Munich, Germany, and its stage is listed as Series A.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in